SEC Form 4 · accession 0001209191-18-016992
ARROWHEAD PHARMACEUTICALS, INC. · ARWR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kenneth Allen Myszkowski
Officer — Chief Financial Officer
Period of report
Mar 5, 2018
Accepted (ET)
Mar 5, 2018 · 8:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000879407
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 5, 2018 | F | 8,208 | $6.66 | D | 310,815 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction reflects the payment of the tax liability by withholding securities incident to the vesting of restricted stock units on 03/05/2018.